human ovarian cancer cell line ho8910 cl-0113 Search Results


ho8910  (Procell Inc)
90
Procell Inc ho8910
Ho8910, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ho8910/product/Procell Inc
Average 90 stars, based on 1 article reviews
ho8910 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cell line a2780 cl-0013  (Procell Inc)
90
Procell Inc cell line a2780 cl-0013
Effects of down‐regulating CCNG1 on the migration and invasion ability of ovarian cancer cell lines. The number of migrating and invasion cells in silenced CCNG1group was significantly reduced in <t>A2780</t> (A) or HO8910 (B). The numerical values were mean ± SD of three replicates. All the experiments were repeated three times using the same batch of cells
Cell Line A2780 Cl 0013, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line a2780 cl-0013/product/Procell Inc
Average 90 stars, based on 1 article reviews
cell line a2780 cl-0013 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mccoy s 5a medium  (Thermo Fisher)
86
Thermo Fisher mccoy s 5a medium
Effects of down‐regulating CCNG1 on the migration and invasion ability of ovarian cancer cell lines. The number of migrating and invasion cells in silenced CCNG1group was significantly reduced in <t>A2780</t> (A) or HO8910 (B). The numerical values were mean ± SD of three replicates. All the experiments were repeated three times using the same batch of cells
Mccoy S 5a Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mccoy s 5a medium/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
mccoy s 5a medium - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

Image Search Results


Effects of down‐regulating CCNG1 on the migration and invasion ability of ovarian cancer cell lines. The number of migrating and invasion cells in silenced CCNG1group was significantly reduced in A2780 (A) or HO8910 (B). The numerical values were mean ± SD of three replicates. All the experiments were repeated three times using the same batch of cells

Journal: Cancer Medicine

Article Title: CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression

doi: 10.1002/cam4.1812

Figure Lengend Snippet: Effects of down‐regulating CCNG1 on the migration and invasion ability of ovarian cancer cell lines. The number of migrating and invasion cells in silenced CCNG1group was significantly reduced in A2780 (A) or HO8910 (B). The numerical values were mean ± SD of three replicates. All the experiments were repeated three times using the same batch of cells

Article Snippet: Human ovarian cancer cell line A2780 (Procell, China, CL‐0013) and HO8910 (Procell, China, CL‐0113) were cultured in RPMI 1640 culture medium and SKOV3 (ATCC, USA, HBT‐77) in McCoy's 5A medium, supplemented with 10% fetal bovine serum (FBS, Gibco).

Techniques: Migration

CCNG1 modulated cisplatin sensitivity. A, After exposure to cisplatin, CCNG1 protein expression in ovarian cancer cells was time‐dependently up‐regulated. B and C, Cell inhibitory rates and IC50 of cisplatin in HO8910 and A2780 were significantly changed after down‐regulation of CCNG1 expression by shRNA. Cell viability detection, from cells seeded in 96‐well plates to calculate IC50, was repeated three times to obtain three IC50

Journal: Cancer Medicine

Article Title: CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression

doi: 10.1002/cam4.1812

Figure Lengend Snippet: CCNG1 modulated cisplatin sensitivity. A, After exposure to cisplatin, CCNG1 protein expression in ovarian cancer cells was time‐dependently up‐regulated. B and C, Cell inhibitory rates and IC50 of cisplatin in HO8910 and A2780 were significantly changed after down‐regulation of CCNG1 expression by shRNA. Cell viability detection, from cells seeded in 96‐well plates to calculate IC50, was repeated three times to obtain three IC50

Article Snippet: Human ovarian cancer cell line A2780 (Procell, China, CL‐0013) and HO8910 (Procell, China, CL‐0113) were cultured in RPMI 1640 culture medium and SKOV3 (ATCC, USA, HBT‐77) in McCoy's 5A medium, supplemented with 10% fetal bovine serum (FBS, Gibco).

Techniques: Expressing, shRNA

Down‐regulation of CCNG1 reduced tumor metastasis in vivo . A, H&E staining of lung metastasis of shCCNG1‐A2780 cell line and its control. B, Nude mice injected with shCCNG1‐A2780 cell line developed fewer lung metastatic foci than its control ( P < 0.0001). C, CCNG1 was regulated by P53mt via induction of Notch3 expression, which ultimately promotes both HGSOC tumor cell metastasis and cisplatin resistance

Journal: Cancer Medicine

Article Title: CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression

doi: 10.1002/cam4.1812

Figure Lengend Snippet: Down‐regulation of CCNG1 reduced tumor metastasis in vivo . A, H&E staining of lung metastasis of shCCNG1‐A2780 cell line and its control. B, Nude mice injected with shCCNG1‐A2780 cell line developed fewer lung metastatic foci than its control ( P < 0.0001). C, CCNG1 was regulated by P53mt via induction of Notch3 expression, which ultimately promotes both HGSOC tumor cell metastasis and cisplatin resistance

Article Snippet: Human ovarian cancer cell line A2780 (Procell, China, CL‐0013) and HO8910 (Procell, China, CL‐0113) were cultured in RPMI 1640 culture medium and SKOV3 (ATCC, USA, HBT‐77) in McCoy's 5A medium, supplemented with 10% fetal bovine serum (FBS, Gibco).

Techniques: In Vivo, Staining, Control, Injection, Expressing